Liver-targeted chemo shows promise for hard-to-treat bile duct cancer

NCT ID NCT03364530

Recruiting now Disease control Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 25 times

Summary

This study tests giving a combination of two chemotherapy drugs directly into the liver artery for people with bile duct cancer that has not spread but cannot be removed by surgery. The goal is to see if this approach can shrink tumors after standard treatment has stopped working. About 40 adults whose cancer is only in the liver will receive the treatment and be monitored for response at 4 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Amiens University Hospital
RECRUITING

Amiens, France

Contact
Angers University Hospital
RECRUITING

Angers, France

Contact
Bordeaux University Hospital
RECRUITING

Bordeaux, France

Contact
Centre Georges François Leclerc
RECRUITING

Dijon, France

Contact
Hôpital Européen Georges Pompidou
RECRUITING

Paris, France

Contact
Institut Gustave Roussy
RECRUITING

Villejuif, France

Contact
Uhmontpellier
RECRUITING

Montpellier, 34295, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHOLANGIOCARCINOMA NON-RESECTABLE NON-METASTATIC